SHC1 and adrenal cortex carcinoma: Furthermore, high SHC1 expression was significantly correlated with poor disease-free survival (DFS) in patients with ACC (p = 0.0016), KIRP (p = 0.0036), LGG (p = 6.6e−05), READ (p = 0.023), and UVM (p = 0.002).